The Spectrum of Neuromyelitis Optica (NMO) in Childhood
- 1 August 2012
- journal article
- review article
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 27 (11), 1437-1447
- https://doi.org/10.1177/0883073812451495
Abstract
The evaluation of inflammatory central nervous system disorders in childhood with predominant involvement of the optic nerves and spinal cord has been greatly enhanced over the last decade with identification of a group of disorders unified by the detection of neuromyelitis optica (NMO)–IgG, an antibody targeting the central nervous system–predominant water channel aquaporin-4. Clinical syndromes are predominated by the relapsing form of NMO but also include encephalopathic variants that can mimic acute disseminated encephalomyelitis. Maintenance immunotherapy is used to prevent relapses in NMO-IgG–seropositive patients. In contrast, NMO-IgG–seronegative children with NMO more commonly have a monophasic course (simultaneous occurrence of optic neuritis and transverse myelitis) and do not require remission-maintaining immunotherapy, but close surveillance is advised. Current clinical, pathological, and pathogenetic knowledge is reviewed with a focus on clinical presentation, neuroimaging findings, serological investigations, and treatment of children with disorders within the spectrum of central nervous system aquaporin-4 autoimmunity.Keywords
This publication has 83 references indexed in Scilit:
- Small‐molecule inhibitors of NMO‐IgG binding to aquaporin‐4 reduce astrocyte cytotoxicity in neuromyelitis opticaThe FASEB Journal, 2012
- Inflammatory Cortical Demyelination in Early Multiple SclerosisNew England Journal of Medicine, 2011
- Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytesProceedings of the National Academy of Sciences of the United States of America, 2011
- Anti–Aquaporin‐4 monoclonal antibody blocker therapy for neuromyelitis opticaAnnals of Neurology, 2011
- Beneficial Plasma Exchange Response in Central Nervous System Inflammatory DemyelinationArchives of Neurology, 2011
- Absence of cortical demyelination in neuromyelitis opticaNeurology, 2010
- Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in miceBrain, 2010
- Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis opticaAnnals of Neurology, 2009
- Aquaporin-4–binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2The Journal of Experimental Medicine, 2008
- Antibody to aquaporin-4 in the long-term course of neuromyelitis opticaBrain, 2008